Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine

• Status: Completed
• Trial end date: 2007-02-28
• Target enrollment: 0
• Participant gender: All

Summary

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Fexofenadine; Fluticasone; Terfenadine; Xhance

Criteria

Inclusion criteria:

• Informed consent.

• Outpatient.

• Females of child-bearing potential must use appropriate contraception.

• Diagnosis of seasonal allergic rhinitis to mountain cedar.

• Adequate exposure to allergen.

• Able to comply with study procedures.

• Literate.

Exclusion criteria:

• Significant concomitant medical condition.

• Use of corticosteroids, allergy medications, or other medication that affect allergic rhinitis

• Positive pregnancy test.

• Allergy to any component of the investigational product.

• Tobacco use

• Contact lens use

• Has chickenpox or measles or recent exposure

• Other clinical trial drug exposure in last 30 days

• Affiliation with clinic site